Skip to content

Clinical trials

Epidermolysis Bullosa Simplex trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epidermolysis Bullosa Simplex Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20152
20162
20173
20182
20202
20211
20221
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status5
Recruiting3
Active, not recruiting1
Terminated1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Castle Creek Pharmaceuticals, LLC3
BioMendics, LLC2
Centre Hospitalier Universitaire de Nice2
Stanford University2
Energenesis Biomedical Co., Ltd.1
InMed Pharmaceuticals Inc.1
Johns Hopkins University1
Joyce Teng1
National Medical Research Center for Children's Health, Russian Federation1
Premier Specialists, Australia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epidermolysis Bullosa Simplex20
Epidermolysis Bullosa8
Epidermolysis Bullosa Dystrophica6
Epidermolysis Bullosa, Junctional5
Skin Diseases3
Skin Diseases, Genetic3
Skin Abnormalities2
Blister1
Endocrine System Diseases1
Ichthyosis1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.